المؤلفون: Geoffrey R. Oxnard, Andrew Weickhardt, D. Ross Camidge, Lecia V. Sequist, Jean Fan, Pasi A. Jänne, Jeanette Alicea, Elizabeth S. Dowling

المصدر: Clinical Lung Cancer. 19:e655-e665

مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Afatinib, Gastroenterology, Cohort Studies, 03 medical and health sciences, T790M, 0302 clinical medicine, Neoplasms, Internal medicine, medicine, Mucositis, Humans, Tissue Distribution, Epidermal growth factor receptor, Adverse effect, Lung cancer, Protein Kinase Inhibitors, Aged, Aged, 80 and over, biology, business.industry, Middle Aged, Prognosis, medicine.disease, Rash, respiratory tract diseases, 030104 developmental biology, Oncology, Tolerability, 030220 oncology & carcinogenesis, biology.protein, Female, medicine.symptom, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7982ba78a2fa76712f8a054139e67543Test
https://doi.org/10.1016/j.cllc.2018.04.015Test

المؤلفون: William Pao, Matthias Freiwald, Vincent A. Miller, Scott N. Gettinger, Leora Horn, Vikram K. Chand, Egbert F. Smit, Bushi Wang, Harry J.M. Groen, D. Ross Camidge, Yelena Y. Janjigian, Jean Fan

المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Pulmonary medicine, CCA - Cancer Treatment and quality of life

المصدر: Horn, L, Gettinger, S, Camidge, D R, Smit, E F, Janjigian, Y Y, Miller, V A, Pao, W, Freiwald, M, Fan, J, Wang, B, Chand, V K & Groen, H J M 2017, ' Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib ', Lung Cancer, vol. 113, pp. 51-58 . https://doi.org/10.1016/j.lungcan.2017.08.014Test
Lung Cancer, 113, 51-58. ELSEVIER IRELAND LTD
Lung Cancer, 113, 51-58. Elsevier Ireland Ltd

مصطلحات موضوعية: MECHANISM, Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Afatinib, medicine.medical_treatment, MULTICENTER, Cetuximab, Kaplan-Meier Estimate, NSCLC, Cohort Studies, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Medicine, Epidermal growth factor receptor, Aged, 80 and over, biology, Gefitinib, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, Rash, ErbB Receptors, 030220 oncology & carcinogenesis, Disease Progression, Female, Erlotinib, medicine.symptom, medicine.drug, Adult, Diarrhea, Pulmonary and Respiratory Medicine, medicine.medical_specialty, EGFR, Phase Ib, RANDOMIZED PHASE-3 TRIAL, Erlotinib Hydrochloride, 03 medical and health sciences, HER2, Internal medicine, TYROSINE KINASE INHIBITORS, Humans, Lung cancer, neoplasms, Aged, Chemotherapy, business.industry, ADENOCARCINOMA, Exanthema, medicine.disease, respiratory tract diseases, 1ST-LINE TREATMENT, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, Quinazolines, biology.protein, GROWTH-FACTOR RECEPTOR, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a28452e64bfdb20e6ab794abd7bf3038Test
https://doi.org/10.1016/j.lungcan.2017.08.014Test

المؤلفون: Lili Wang, Jean Fan, Angela N. Brooks, Rutendo Gambe, Benjamin L. Ebert, Youzhong Wan, Sarah Hergert, Catherine J. Wu, Matthew Meyerson, Donna Neuberg, Mark D. Fleming, Jing Sun, Peter V. Kharchenko

المصدر: Clinical Lymphoma Myeloma and Leukemia. 16:S52

مصطلحات موضوعية: Cancer Research, Oncology, business.industry, Chronic lymphocytic leukemia, Mutation (genetic algorithm), Cancer research, medicine, Hematology, medicine.disease, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8e342004fba9fc0c1ccd47d51be30c3eTest
https://doi.org/10.1016/j.clml.2016.07.076Test